Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2 (2022)
Attributed to:
Structural Studies on Viruses, Viral Proteins and Cell Interactions
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.07.14.500063
Publication URI: http://dx.doi.org/10.1101/2022.07.14.500063
Type: Preprint